Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 26,218 | 24,289 | 21,194 | 20,923 | 8,982 |
| Cost of Goods | 24,568 | 25,330 | 28,643 | 24,445 | 17,951 |
| Gross Profit | 1,650 | -1,041 | -7,449 | -3,522 | -8,969 |
| Operating Expenses | 61,731 | 71,755 | 64,815 | 58,140 | 57,222 |
| Operating Income | -59,513 | -72,466 | -71,621 | -61,217 | -65,240 |
| Interest Expense | 11,124 | 22,836 | 10,520 | -6,829 | 10,143 |
| Other Income | -98 | 3,788 | 3,555 | 6,868 | 7,447 |
| Pre-tax Income | -70,735 | -91,514 | -78,586 | -47,520 | -67,936 |
| Income Tax | 863 | -1,182 | 532 | 397 | 2,225 |
| Net Income Continuous | -71,598 | -90,332 | -79,118 | -47,917 | -70,161 |
| Net Income | $-71,598 | $-90,332 | $-79,118 | $-47,917 | $-70,161 |
| EPS Basic Total Ops | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| EPS Basic Continuous Ops | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| EPS Diluted Total Ops | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| EPS Diluted Continuous Ops | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| EBITDA(a) | $-56,814 | $-69,835 | $-69,083 | $-58,849 | $-62,963 |